Takao S - Search Results

1

Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13).

Miki M, Takao S, Konishi M, Shigeoka Y, Miyashita M, Suwa H, Miyoshi Y, Hirokaga K, Okuno T, Yamagami K, Imamura M, Murase K, Yanai A, Tanino H. Miki M, et al. Among authors: takao s. Anticancer Res. 2021 Jun;41(6):3121-3126. doi: 10.21873/anticanres.15096. Anticancer Res. 2021. PMID: 34083305

2

Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation.

Monzawa S, Yokokawa M, Sakuma T, Takao S, Hirokaga K, Hanioka K, Adachi S. Monzawa S, et al. Among authors: takao s. AJR Am J Roentgenol. 2009 Mar;192(3):W125-31. doi: 10.2214/AJR.07.4021. AJR Am J Roentgenol. 2009. PMID: 19234240

3

[Clinical significance of intratumoral TS levels and DPD activity in breast cancer].

Miyashita M, Yoshimura H, Hatta K, Tachibana S, Kubota M, Takahashi H, Yamazaki Y, Maeda K, Okita Y, Takao S. Miyashita M, et al. Among authors: takao s. Gan To Kagaku Ryoho. 2009 Mar;36(3):407-11. Gan To Kagaku Ryoho. 2009. PMID: 19295264 Japanese.

4

Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.

Monzawa S, Adachi S, Suzuki K, Hirokaga K, Takao S, Sakuma T, Hanioka K. Monzawa S, et al. Among authors: takao s. Ann Nucl Med. 2009 Dec;23(10):855-61. doi: 10.1007/s12149-009-0314-9. Epub 2009 Oct 30. Ann Nucl Med. 2009. PMID: 19876704

5

Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study.

Takao S, Tokuda Y, Saeki T, Funai J, Ishii M, Takashima S. Takao S, et al. Breast Cancer. 2012 Oct;19(4):335-42. doi: 10.1007/s12282-011-0289-y. Epub 2011 Jul 13. Breast Cancer. 2012. PMID: 21751001 Clinical Trial.

6

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

Tanioka M, Sasaki M, Shimomura A, Fujishima M, Doi M, Matsuura K, Sakuma T, Yoshimura K, Saeki T, Ohara M, Tsurutani J, Watatani M, Takano T, Kawabata H, Mukai H, Naito Y, Hirokaga K, Takao S, Minami H. Tanioka M, et al. Among authors: takao s. Breast. 2014 Aug;23(4):466-72. doi: 10.1016/j.breast.2014.03.008. Epub 2014 Apr 16. Breast. 2014. PMID: 24742606 Free article.

7

[A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].

Miki M, Matsuo Y, Yoshida S, Tane K, Hirokaga K, Maekawa Y, Takao S. Miki M, et al. Among authors: takao s. Gan To Kagaku Ryoho. 2014 Aug;41(8):1027-9. Gan To Kagaku Ryoho. 2014. PMID: 25132039 Japanese.

8

Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.

Tanioka M, Sakai K, Sudo T, Sakuma T, Kajimoto K, Hirokaga K, Takao S, Negoro S, Minami H, Nakagawa K, Nishio K. Tanioka M, et al. Among authors: takao s. Breast Cancer Res Treat. 2014 Oct;147(3):513-25. doi: 10.1007/s10549-014-3121-5. Epub 2014 Sep 9. Breast Cancer Res Treat. 2014. PMID: 25200445 Clinical Trial.

9

Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.

Egawa C, Hirokaga K, Takao S, Yamagami K, Miyashita M, Baba M, Ichii S, Konishi M, Kikawa Y, Minohata J, Okuno T, Miyauchi K, Wakita K, Suwa H, Hashimoto T, Nishino M, Matsumoto T, Hidaka T, Konishi Y, Sakoda Y, Miya A, Mitsunobu M, Nishikawa H, Kono S, Kokufu I, Sakita I, Kitatsuji K, Oh K, Miyoshi Y. Egawa C, et al. Among authors: takao s. Int J Clin Oncol. 2016 Apr;21(2):262-269. doi: 10.1007/s10147-015-0905-5. Epub 2015 Sep 28. Int J Clin Oncol. 2016. PMID: 26411314

10

Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.

Takashima T, Mukai H, Hara F, Matsubara N, Saito T, Takano T, Park Y, Toyama T, Hozumi Y, Tsurutani J, Imoto S, Watanabe T, Sagara Y, Nishimura R, Shimozuma K, Ohashi Y; SELECT BC Study Group. Takashima T, et al. Lancet Oncol. 2016 Jan;17(1):90-8. doi: 10.1016/S1470-2045(15)00411-8. Epub 2015 Nov 27. Lancet Oncol. 2016. PMID: 26617202 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

823 results

Search Page

Filters